|
Volumn 15, Issue 1, 2001, Pages 2-4
|
Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
DEXAMETHASONE;
DNA;
FLURBIPROFEN;
I KAPPA B;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
ISOENZYME;
LIPOPOLYSACCHARIDE;
MESSENGER RNA;
PROSTAGLANDIN;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
TRANSCRIPTION FACTOR AP 1;
ACTIVE TRANSPORT;
ANIMAL;
ARTICLE;
CELL LINE;
CHEMICALLY INDUCED DISORDER;
CHEMISTRY;
CYTOLOGY;
DISEASE MODEL;
DRUG ANTAGONISM;
DRUG EFFECT;
GENETICS;
INFLAMMATION;
ISOMERISM;
MACROPHAGE;
METABOLISM;
MOUSE;
PATHOLOGY;
PHOSPHORYLATION;
RAT;
SPINAL CORD;
TRANSACTIVATION;
ACTIVE TRANSPORT, CELL NUCLEUS;
ANIMALS;
CELL LINE;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DEXAMETHASONE;
DISEASE MODELS, ANIMAL;
DNA;
FLURBIPROFEN;
I-KAPPA B PROTEINS;
INFLAMMATION;
ISOENZYMES;
ISOMERISM;
LIPOPOLYSACCHARIDES;
MACROPHAGES;
MICE;
NF-KAPPA B;
PHOSPHORYLATION;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PROSTAGLANDINS;
RATS;
RNA, MESSENGER;
SPINAL CORD;
TRANS-ACTIVATION (GENETICS);
TRANSCRIPTION FACTOR AP-1;
MLCS;
MLOWN;
|
EID: 0035220745
PISSN: 08926638
EISSN: None
Source Type: Journal
DOI: 10.1096/fasebj.15.1.2 Document Type: Article |
Times cited : (68)
|
References (0)
|